GlassScriptPhysician profile
Tena Tully
NPI 1306431549
$573.93
in general payments reported to CMS, 2019-2025
16 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $76.87 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $83.49 | 2025 | Myrisk, Prolaris |
| Janssen Biotech, INC. | $69.23 | 2025 | Erleada |
| Merck Sharp & Dohme LLC | $56.58 | 2025 | Keytruda |
| Abbvie INC. | $46.38 | 2024 | |
| Ferring Pharmaceuticals INC. | $40.53 | 2025 | Adstiladrin |
| Immunitybio, INC. | $36.15 | 2025 | |
| Pfizer INC. | $30.49 | 2024 | |
| Endo USA, INC. | $29.18 | 2025 | Xiaflex |
| Boston Scientific Corporation | $26.33 | 2025 | Solyx Sis System |
| Dendreon Pharmaceuticals LLC | $25.54 | 2025 | Provenge |
| Antares Pharma, INC. | $25.12 | 2025 | Xyosted |
| Tempus Ai, INC | $25.01 | 2025 | Xt Cdx |
| Tolmar, INC. | $23.83 | 2025 | Eligard, Jatenzo |
| 180 Medical, INC. | $19.93 | 2025 | Gentlecath |
| Abc Home Medical Supply, INC. | $19.73 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $16.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tena Tully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.